The Efficacy and Safety of Irinotecan Plus Temozolomide and Vincristine in Neuroblastoma with Brain Recurrence: A Retrospective Study

被引：0
|
作者：
Wang, J. [1 ]
Zhen, Z. [2 ]
Zhu, S. [3 ]
Lian, Z. [4 ]
Lu, S. [2 ]
Sun, F. [2 ]
Huang, J. [2 ]
Zhang, Y. [5 ]
Sun, X. [1 ]
机构：
[1] Sun Yat Sen Univ, Ctr Canc, Pediat Oncol, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Canc Ctr, Dept Pediat Oncol, Guangzhou, Peoples R China
[3] Capital Med Univ, Natl Ctr Childrens Hlth, Beijing Childrens Hosp, Med Oncol Dept, Beijing, Peoples R China
[4] Sun Yat Sen Univ, Ctr Canc, Pediat Oncol, Guangzhou, Peoples R China
[5] Sun Yat Sen Univ, Ctr Canc, Dept Pediat Oncol, Guangzhou, Peoples R China
来源：
PEDIATRIC BLOOD & CANCER | 2021年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PV0126
引用
收藏
页码：S213 / S214
页数：2
相关论文
共 50 条
  • [21] A retrospective analysis of efficacy and safety of irinotecan plus cisplatin in ED-SCLC patients with pleural effusion
    Sano, Yoshiyuki
    Morita, Tomoko
    Kirita, Keisuke
    Umemura, Shigeki
    Matsumoto, Shingo
    Yoh, Kiyotaka
    Niho, Seiji
    Ohmatsu, Hironobu
    Goto, Koichi
    Saitoh, Shinichiro
    ANNALS OF ONCOLOGY, 2016, 27
  • [22] Triple-drug Therapy With Bevacizumab, Irinotecan, and Temozolomide Plus Tumor Treating Fields for Recurrent Glioblastoma: A Retrospective Study
    Lu, Guangrong
    Rao, Mayank
    Zhu, Ping
    Liang, Buqing
    El-Nazer, Rasheda T.
    Fonkem, Ekokobe
    Bhattacharjee, Meenakshi B.
    Zhu, Jay-Jiguang
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [23] Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II study
    Modak, Shakeel
    Kushner, Brian H.
    Basu, Ellen
    Roberts, Stephen S.
    Cheung, Nai-Kong V.
    PEDIATRIC BLOOD & CANCER, 2017, 64 (08)
  • [24] Pilot study of vincristine, oral irinotecan, and temozolomide (VOIT regimen) combined with bevacizumab in pediatric patients with recurrent solid tumors or brain tumors
    Wagner, Lars
    Turpin, Brian
    Nagarajan, Rajaram
    Weiss, Brian
    Cripe, Timothy
    Geller, James
    PEDIATRIC BLOOD & CANCER, 2013, 60 (09) : 1447 - 1451
  • [25] Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan
    Zuniga, R. M.
    Torcuator, R.
    Jain, R.
    Anderson, J.
    Doyle, T.
    Ellika, S.
    Schultz, L.
    Mikkelsen, T.
    JOURNAL OF NEURO-ONCOLOGY, 2009, 91 (03) : 329 - 336
  • [26] Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan
    R. M. Zuniga
    R. Torcuator
    R. Jain
    J. Anderson
    T. Doyle
    S. Ellika
    L. Schultz
    T. Mikkelsen
    Journal of Neuro-Oncology, 2009, 91 : 329 - 336
  • [27] Safety and efficacy of the addition of bevacizumab to temozolomide and radiation therapy followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma multiforme
    Vredenburgh, James J.
    Desjardins, Annick
    Peters, Katherine B.
    Reardon, David A.
    Herndon, James Emmett
    Coan, April D.
    Kirkpatrick, John
    Bailey, Leighann
    Threatt, Stevie
    Sampson, John Howard
    Friedman, Allan H.
    Friedman, Henry S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [28] A Phase I Study of Vincristine, Irinotecan, Temozolomide and Bevacizumab (Vitb) in Pediatric Patients with Relapsed Solid Tumors
    Venkatramani, Rajkumar
    Malogolowkin, Marcio
    Davidson, Tom B.
    May, William
    Sposto, Richard
    Mascarenhas, Leo
    PLOS ONE, 2013, 8 (07):
  • [29] Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
    Xu, Qingsheng
    Huang, Kaiyuan
    Meng, Xiangqi
    Weng, Yuxiang
    Zhang, Luyuan
    Bu, Linghao
    Zheng, Xiujue
    Cai, Jinquan
    Zhan, Renya
    Chen, Qun
    CLINICAL CANCER RESEARCH, 2023, 29 (19) : 3859 - 3866
  • [30] A Retrospective Study Investigating the Safety and Efficacy of Nanoliposomal Irinotecan in Elderly Patients with Unresectable Pancreatic Cancer
    Ikoma, Tatsuki
    Matsumoto, Toshihiko
    Boku, Shogen
    Yasuda, Tomoyo
    Masuda, Masataka
    Ito, Takashi
    Nakamaru, Koh
    Yamaki, So
    Nakayama, Shinji
    Hashimoto, Daisuke
    Yamamoto, Tomohisa
    Shibata, Nobuhiro
    Ikeura, Tsukasa
    Naganuma, Makoto
    Satoi, Sohei
    Kurata, Takayasu
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (10)
12345